| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
,
J. F. MORTOLA
,
G. A. LAUGHLIN and
S. S. C. YEN
Department of Reproductive Medicine, School of Medicine (T-002), and the General Clinical Research Center, University of California-San Diego La Jolla, California 92093
Address all correspondence and requests for reprints to: Dr. S. S. C. Yen, Department of Reproductive Medicine (T-002), University of California-San Diego, La Jolla, California 92093.
Dopamine (DA) inhibits pituitary TSH release, but its role as a regulator of circadian and pulsatile TSH secretion is not clear. Accordingly, we studied the 24-h TSH secretory patterns in seven normal women in the early follicular phase of their cycles before and during DA receptor blockade by metoclopramide (MCP). Serum TSH was measured by a highly sensitive (0.05 mU/L) RIA at 15-min intervals for 48 h during sequential 24-h saline and 24-h MCP infusions (30 µg/kg·h). Sleep was confirmed by electroencephalogram between 2300–0700 h. All women had a nocturnal rise of TSH, independent of sleep, which began in the late afternoon and reached a peak (acrophase) after midnight during the saline infusion. This circadian periodicity was composed of a series of TSH pulses with greater magnitude and frequency during nocturnal hours. Infusion of MCP had no effect on pulse frequency, but the pulse amplitude increased (P < 0.05), especially at night. As a consequence, the circadian excursion of TSH, as assessed by cosinor function, was exaggerated. The mean acrophase amplitude and mesor levels increased (P < 0.05), but the nadir and acrophase times did not change. These findings suggest that DA is an inhibitor of TSH pulse amplitude throughout the 24-h biological clock. By inference, the neuroendocrine mechanism(s) that underlies the nocturnal increase in TSH secretion is not due to decreased dopaminergic inhibition.
* This work was supported by NIH/NICHHD Research Center Grants HD-12303 and HD-21198, and in part by the UCSD General Clinical Research Center NIH/Division of Research Resources Grant RR-00827. This research was conducted in part by the Clayton Foundation for Research, California Division.
Research Fellow, recipient of German Research Foundation Grant Ro 657/1-2. Present address: Department of Obstetrics and Gynecology, University of Ulm, Prittwitzstrasse 43, D-7900 Ulm/D., West Germany.
Andrew Mellon Foundation Faculty Scholar.
Clayton Foundation Investigator.
Received January 27, 1988.
This article has been cited by other articles:
![]() |
P. Kok, F. Roelfsema, M. Frolich, J. van Pelt, A. E. Meinders, and H. Pijl Bromocriptine Reduces Augmented Thyrotropin Secretion in Obese Premenopausal Women J. Clin. Endocrinol. Metab., April 1, 2009; 94(4): 1176 - 1181. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Mantzoros, M. Ozata, A. B. Negrao, M. A. Suchard, M. Ziotopoulou, S. Caglayan, R. M. Elashoff, R. J. Cogswell, P. Negro, V. Liberty, et al. Synchronicity of Frequently Sampled Thyrotropin (TSH) and Leptin Concentrations in Healthy Adults and Leptin-Deficient Subjects: Evidence for Possible Partial TSH Regulation by Leptin in Humans J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3284 - 3291. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Zimmermann, L. E. Krahn, G. G. Klee, E. C. Ditkoff, S. J. Ory, and M. V. Sauer Prolonged Inhibition of Presynaptic Catecholamine Synthesis With {alpha}-Methyl-Para-Tyrosine Attenuates the Circadian Rhythm of Human TSH Secretion Reproductive Sciences, May 1, 2001; 8(3): 174 - 178. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |